Skip to main content
Vai all'homepage della Commissione europea (si apre in una nuova finestra)
italiano it
CORDIS - Risultati della ricerca dell’UE
CORDIS

A study to establish the technical and economic feasibility of a mobile DNA and RNA testing tool, for use in general clinics and homecare.

Obiettivo

As DNA testing is most commonly centralised in labs, it lacks the turnaround time for time-sensitive applications, and also lacks mobility. The experience in biology required to prepare samples and carry out testing obfuscate the process and limit point-of-care applications. Biomeme seeks to break down these barriers with their versatile Dx System, a holistic solution to bring DNA testing out of the labs and into the physician’s office. Thus, Biomeme provides Molecular Diagnostics for the on-demand economy. By simplifying the process of DNA testing, without sacrificing the detail to be found in raw data, the Biomeme solution brings molecular diagnostic into point-of-care medical services, making it available for homecare and other point-of-need uses.

Campo scientifico (EuroSciVoc)

Programma(i)

Argomento(i)

Meccanismo di finanziamento

SME-1 - SME instrument phase 1

Vedi tutti i progetti finanziati nell’ambito di questo schema di finanziamento

Invito a presentare proposte

(si apre in una nuova finestra) H2020-SMEInst-2016-2017

Vedi tutti i progetti finanziati nell’ambito del bando

Coordinatore

BIOMEME UK LTD
Contributo netto dell'UE
€ 50 000,00
Indirizzo
72 GREAT SUFFOLK STREET
SE1 0BL LONDON
Regno Unito
PMI
Sì
Regione
London Inner London — East Lewisham and Southwark
Tipo di attività
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Collegamenti
Costo totale
€ 71 429,00

Partecipanti (1)